Outcomes Following Autologous Stem Cell Transplantation (ASCT) In Patients With Germinal Center B (GCB) and Non-GCB Cell-Like Diffuse Large B Cell Lymphomas (DLBCL) According To Conditioning With BEAM-Rituximab (Standard vs. High-Dose) Vs. BEAM/Yttrium-90 Ibritumomab Tiuxetan ((YIT)-Y-90)


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Khouri, IF; Saliba, RM; Xu-Monette, ZY; Rondon, G; Valverde, R; Korbling, M; Gulbis, AM; Anderlini, P; Sairah, A; Hosing, CM; Popat, UR; Kebriaei, P; Fayad, LE; Westin, JR; Turturro, F; Medeiros, LJ; Champlin, RE; Young, KH

Published Date

  • November 15, 2013

Published In

Volume / Issue

  • 122 / 21

Published By


  • 2

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 55th Annual Meeting of the American-Society-of-Hematology

Conference Location

  • New Orleans, LA

Conference Start Date

  • December 7, 2013

Conference End Date

  • December 10, 2013